|
|
|
|
|
|
|
Insulet Corp (PODD)
|
|
87.49 -1.43 (-1.61%)
|
05-22 16:00
|
|
Open:
|
89.22
|
Pre. Close:
|
88.92
|
|
High:
|
89.4
|
Low:
|
86.92
|
|
Volume:
|
180,796
|
Market Cap:
|
5140M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
89.531 - 89.983
|
89.983 - 90.354
|
|
Low:
|
85.886 - 86.359
|
86.359 - 86.749
|
|
Close:
|
86.796 - 87.538
|
87.538 - 88.149
|
|
|
|
Technical analysis (as of: 2018-05-22 4:42:05 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 104.21 One year: 110.10
|
|
Support:
|
Support1: 81.06 Support2: 67.44
|
|
Resistance:
|
Resistance1:
89.22 Resistance2: 94.26
|
|
Pivot:
|
86.21 
|
|
Moving Averages:
|
MA(5): 87.69 MA(20): 86.24
MA(100): 80.62 MA(250): 66.74
|
|
MACD:
|
MACD(12,26):
0.68 Signal(12,26,9): 0.48
|
|
%K %D:
|
%K(14,3): 52.40 %D(3): 50.85
|
|
RSI:
|
RSI(14): 55.32
|
|
52-Week:
|
High: 94.26
Low: 40.92 Change(%): 106.5
|
|
Average Vol(K):
|
3-Month: 41632
10-Days 31513
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.PODD has closed below upper band by 31.0%. Bollinger Bands are 13.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-05-03T22:46:25-04:00
Insulet (PODD) Q1 2018 Results - Earnings Call Transcript
2018-05-03T16:17:33-04:00
Insulet beats by $0.08, beats on revenue
2018-05-03T16:01:00-04:00
Insulet Reports First Quarter 2018 Revenue of $123.6 Million, Up 21% Year-Over-Year, and Gross Margin of 61.4%, Up 300 Basis Points, Exceeding Expectations
2018-05-03T05:00:00-04:00
Insulet Achieves Key Milestones to Support its Transition to Direct Operations in Europe on July 1, 2018
2018-05-02T17:35:22-04:00
Notable earnings after Thursday's close
2018-04-05T06:00:00-04:00
Insulet to Announce First Quarter 2018 Financial Results on May 3, 2018
2018-04-04T08:26:59-04:00
Premarket analyst action - healthcare
2018-03-27T15:50:45-04:00
FDA OKs DexCom G6 integrated CGM system
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
